Daniel O'Connor Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Daniel O'Connor.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Daniel O'Connor. Daniel O'Connor is Director in SEELOS THERAPEUTICS, INC. ($APRI) and Chief Executive Officer in Advaxis, Inc. ($ADXS) and CEO in ONCOSEC MEDICAL Inc ($ONCS) and CEO & President in ONCOSEC MEDICAL Inc ($ONCS) and CEO and President in ONCOSEC MEDICAL Inc ($ONCS) and Chief Executive Officer in ONCOSEC MEDICAL Inc ($ONCS) and Director in ONCOSEC MEDICAL Inc ($ONCS).
Latest Insider Trading Transactions of Daniel O'Connor
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADXS, ONCS, SEEL
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 04 2021 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Sell | S | 4.86 | 3,172 | 15,416 | 96,097 | 99.3 K to 96.1 K (-3.20 %) |
| Feb 02 2021 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Sell | S | 7.71 | 3,413 | 26,314 | 99,269 | 102.7 K to 99.3 K (-3.32 %) |
| Nov 03 2020 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Sell | S | 3.79 | 3,280 | 12,431 | 102,682 | 106 K to 102.7 K (-3.10 %) |
| Aug 26 2020 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Option Exercise | A | 3.82 | 152,000 | 580,640 | 152,000 | |
| Aug 04 2020 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Sell | S | 4.20 | 3,133 | 13,159 | 105,962 | 109.1 K to 106 K (-2.87 %) |
| Aug 04 2020 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Sell | S | 4.20 | 3,133 | 13,159 | 105,962 | 109.1 K to 106 K (-2.87 %) |
| Jun 03 2020 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Option Exercise | A | 1.56 | 304,000 | 474,240 | 304,000 | |
| Jun 03 2020 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Payment of Exercise | F | 2.23 | 44,471 | 99,170 | 109,095 | 153.6 K to 109.1 K (-28.96 %) |
| Jun 03 2020 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Grant | A | 0.00 | 90,580 | 0 | 153,566 | 63 K to 153.6 K (+143.81 %) |
| May 04 2020 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Sell | S | 1.79 | 3,075 | 5,504 | 62,986 | 66.1 K to 63 K (-4.65 %) |
| Feb 03 2020 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Sell | S | 1.96 | 2,654 | 5,202 | 66,061 | 68.7 K to 66.1 K (-3.86 %) |
| Jan 07 2020 | SEEL | SEELOS THERAPEUTIC ... | O'Connor Daniel J. | Director | Option Exercise | A | 1.42 | 16,000 | 22,720 | 16,000 | |
| Nov 01 2019 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Sell | S | 2.16 | 2,128 | 4,596 | 68,715 | 70.8 K to 68.7 K (-3.00 %) |
| Nov 01 2019 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Sell | S | 2.16 | 2,128 | 4,596 | 68,715 | 70.8 K to 68.7 K (-3.00 %) |
| Aug 02 2019 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Payment of Exercise | F | 2.23 | 2,156 | 4,808 | 70,843 | 73 K to 70.8 K (-2.95 %) |
| May 02 2019 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Payment of Exercise | F | 0.57 | 21,357 | 12,067 | 729,992 | 751.3 K to 730 K (-2.84 %) |
| Mar 21 2019 | APRI | SEELOS THERAPEUTIC ... | O'Connor Daniel J. | Director | Option Exercise | A | 2.33 | 16,000 | 37,280 | 16,000 | |
| Mar 21 2019 | APRI | SEELOS THERAPEUTIC ... | O'Connor Daniel J. | Director | Option Exercise | A | 2.33 | 24,000 | 55,920 | 24,000 | |
| Feb 01 2019 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Payment of Exercise | F | 0.88 | 25,318 | 22,280 | 751,349 | 776.7 K to 751.3 K (-3.26 %) |
| Dec 27 2018 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Grant | A | 0.00 | 750,000 | 0 | 776,667 | 26.7 K to 776.7 K (+2,812.46 %) |
| Dec 27 2018 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO and President | Grant | A | 0.00 | 750,000 | 0 | 776,667 | 26.7 K to 776.7 K (+2,812.46 %) |
| Nov 07 2018 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO & President | Buy | P | 0.91 | 10,000 | 9,100 | 26,667 | 16.7 K to 26.7 K (+60.00 %) |
| May 07 2018 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | Chief Executive Off ... | Option Exercise | A | 1.47 | 250,000 | 367,500 | 2,850,000 | |
| Feb 06 2018 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO | Buy | P | 1.50 | 16,667 | 25,001 | 16,667 | 0 to 16.7 K |
| Jan 17 2018 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO | Option Exercise | A | 1.25 | 500,000 | 625,000 | 500,000 | |
| Jan 17 2018 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel J. | CEO | Option Exercise | A | 1.25 | 2,000,000 | 2,500,000 | 2,000,000 | |
| Sep 11 2017 | ONCS | ONCOSEC MEDICAL In ... | O'Connor Daniel | Director | Option Exercise | A | 1.08 | 100,000 | 108,000 | 100,000 | |
| Jul 03 2017 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 6.49 | 742 | 4,816 | 618,352 | 617.6 K to 618.4 K (+0.12 %) |
| Jun 20 2017 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 0.00 | 177,102 | 0 | 617,610 | 440.5 K to 617.6 K (+40.20 %) |
| Jun 01 2017 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 8.07 | 421 | 3,397 | 440,508 | 440.1 K to 440.5 K (+0.10 %) |
| May 01 2017 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 0.00 | 142,996 | 0 | 440,087 | 297.1 K to 440.1 K (+48.13 %) |
| May 01 2017 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 8.56 | 349 | 2,987 | 297,091 | 296.7 K to 297.1 K (+0.12 %) |
| Apr 03 2017 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 8.17 | 365 | 2,982 | 296,742 | 296.4 K to 296.7 K (+0.12 %) |
| Mar 01 2017 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Payment of Exercise | F | 8.79 | 104 | 914 | 296,377 | 296.5 K to 296.4 K (-0.04 %) |
| Mar 01 2017 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 8.79 | 490 | 4,307 | 296,481 | 296 K to 296.5 K (+0.17 %) |
| Feb 02 2017 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Payment of Exercise | F | 8.96 | 97 | 869 | 295,991 | 296.1 K to 296 K (-0.03 %) |
| Feb 02 2017 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 8.96 | 466 | 4,175 | 296,088 | 295.6 K to 296.1 K (+0.16 %) |
| Jan 03 2017 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Payment of Exercise | F | 7.16 | 192 | 1,375 | 295,622 | 295.8 K to 295.6 K (-0.06 %) |
| Jan 03 2017 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 7.16 | 792 | 5,671 | 295,814 | 295 K to 295.8 K (+0.27 %) |
| Dec 01 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Payment of Exercise | F | 8.31 | 89 | 740 | 295,022 | 295.1 K to 295 K (-0.03 %) |
| Dec 01 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 8.31 | 455 | 3,781 | 295,111 | 294.7 K to 295.1 K (+0.15 %) |
| Nov 07 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Option Exercise | A | 7.71 | 170,234 | 1,312,504 | 170,234 | |
| Nov 02 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Sell | S | 8.32 | 8,240 | 68,557 | 294,656 | 302.9 K to 294.7 K (-2.72 %) |
| Nov 02 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Payment of Exercise | F | 8.09 | 231 | 1,869 | 302,896 | 303.1 K to 302.9 K (-0.08 %) |
| Nov 02 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 8.09 | 467 | 3,778 | 303,127 | 302.7 K to 303.1 K (+0.15 %) |
| Oct 04 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Payment of Exercise | F | 10.69 | 50 | 535 | 302,660 | 302.7 K to 302.7 K (-0.02 %) |
| Oct 04 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 10.69 | 354 | 3,784 | 302,710 | 302.4 K to 302.7 K (+0.12 %) |
| Sep 01 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Payment of Exercise | F | 11.53 | 46 | 530 | 302,356 | 302.4 K to 302.4 K (-0.02 %) |
| Sep 01 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 11.53 | 328 | 3,782 | 302,402 | 302.1 K to 302.4 K (+0.11 %) |
| Aug 01 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Payment of Exercise | F | 8.34 | 562 | 4,687 | 310,341 | 310.9 K to 310.3 K (-0.18 %) |
| Aug 01 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 8.34 | 1,133 | 9,449 | 310,903 | 309.8 K to 310.9 K (+0.37 %) |
| Jul 01 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Payment of Exercise | F | 8.09 | 551 | 4,458 | 309,770 | 310.3 K to 309.8 K (-0.18 %) |
| Jul 01 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 8.09 | 1,752 | 14,174 | 310,321 | 308.6 K to 310.3 K (+0.57 %) |
| Jun 01 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Payment of Exercise | F | 9.26 | 268 | 2,482 | 308,569 | 308.8 K to 308.6 K (-0.09 %) |
| Jun 01 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 9.26 | 1,020 | 9,445 | 308,837 | 307.8 K to 308.8 K (+0.33 %) |
| May 02 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Sell | S | 7.51 | 8,237 | 61,860 | 307,817 | 316.1 K to 307.8 K (-2.61 %) |
| May 02 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Payment of Exercise | F | 7.74 | 607 | 4,698 | 316,054 | 316.7 K to 316.1 K (-0.19 %) |
| May 02 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 7.74 | 1,221 | 9,451 | 316,661 | 315.4 K to 316.7 K (+0.39 %) |
| Apr 01 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Payment of Exercise | F | 9.03 | 275 | 2,483 | 315,440 | 315.7 K to 315.4 K (-0.09 %) |
| Apr 01 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 9.03 | 1,046 | 9,445 | 315,715 | 314.7 K to 315.7 K (+0.33 %) |
| Mar 01 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Payment of Exercise | F | 5.46 | 455 | 2,484 | 314,669 | 315.1 K to 314.7 K (-0.14 %) |
| Mar 01 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 5.46 | 1,730 | 9,446 | 315,124 | 313.4 K to 315.1 K (+0.55 %) |
| Feb 01 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Sell | S | 6.88 | 8,818 | 60,668 | 313,394 | 322.2 K to 313.4 K (-2.74 %) |
| Feb 01 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Payment of Exercise | F | 6.82 | 688 | 4,692 | 322,212 | 322.9 K to 322.2 K (-0.21 %) |
| Feb 01 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 6.82 | 1,300 | 8,866 | 322,900 | 321.6 K to 322.9 K (+0.40 %) |
| Jan 04 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Payment of Exercise | F | 10.06 | 296 | 2,978 | 332,953 | 333.2 K to 333 K (-0.09 %) |
| Jan 04 2016 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 10.06 | 1,061 | 10,674 | 333,249 | 332.2 K to 333.2 K (+0.32 %) |
| Dec 01 2015 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Payment of Exercise | F | 12.07 | 133 | 1,605 | 332,190 | 332.3 K to 332.2 K (-0.04 %) |
| Dec 01 2015 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 12.07 | 590 | 7,121 | 332,323 | 331.7 K to 332.3 K (+0.18 %) |
| Nov 06 2015 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Option Exercise | A | 12.81 | 450,000 | 5,764,500 | 450,000 | |
| Nov 03 2015 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Sell | S | 12.26 | 8,350 | 102,371 | 331,733 | 340.1 K to 331.7 K (-2.46 %) |
| Nov 03 2015 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Payment of Exercise | F | 11.09 | 321 | 3,560 | 340,083 | 340.4 K to 340.1 K (-0.09 %) |
| Nov 03 2015 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 11.09 | 641 | 7,109 | 340,404 | 339.8 K to 340.4 K (+0.19 %) |
| Oct 01 2015 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Payment of Exercise | F | 10.23 | 159 | 1,627 | 339,763 | 339.9 K to 339.8 K (-0.05 %) |
| Oct 01 2015 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 10.23 | 695 | 7,110 | 339,922 | 339.2 K to 339.9 K (+0.20 %) |
| Sep 02 2015 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Payment of Exercise | F | 14.80 | 109 | 1,613 | 339,227 | 339.3 K to 339.2 K (-0.03 %) |
| Sep 02 2015 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 14.80 | 480 | 7,104 | 339,336 | 338.9 K to 339.3 K (+0.14 %) |
| Aug 04 2015 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Sell | S | 15.44 | 8,449 | 130,453 | 338,856 | 347.3 K to 338.9 K (-2.43 %) |
| Aug 04 2015 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Payment of Exercise | F | 16.66 | 325 | 5,415 | 347,305 | 347.6 K to 347.3 K (-0.09 %) |
| Aug 04 2015 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 16.66 | 640 | 10,662 | 347,630 | 347 K to 347.6 K (+0.18 %) |
| Jul 01 2015 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Payment of Exercise | F | 20.33 | 8 | 163 | 346,990 | 347 K to 347 K (0.00 %) |
| Jul 01 2015 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 20.33 | 349 | 7,095 | 346,998 | 346.6 K to 347 K (+0.10 %) |
| Jun 02 2015 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 25.16 | 282 | 7,095 | 358,048 | 357.8 K to 358 K (+0.08 %) |
| May 01 2015 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 16.81 | 413 | 6,943 | 357,766 | 357.4 K to 357.8 K (+0.12 %) |
| Apr 01 2015 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Option Exercise | A | 13.44 | 670,000 | 9,004,800 | 670,000 | |
| Apr 01 2015 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 14.44 | 461 | 6,657 | 357,353 | 356.9 K to 357.4 K (+0.13 %) |
| Mar 02 2015 | ADXS | Advaxis, Inc. | O'Connor Daniel | Chief Executive Off ... | Grant | A | 9.00 | 740 | 6,660 | 356,892 | 356.2 K to 356.9 K (+0.21 %) |
Page: 1